ROYAL BANK OF CANADA - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 30 filers reported holding APTEVO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,000
+50.0%
1,700
+138.1%
0.00%
Q3 2022$2,000
-33.3%
7140.0%0.00%
Q2 2022$3,000
-66.7%
714
-55.8%
0.00%
Q1 2022$9,000
-30.8%
1,6140.0%0.00%
Q4 2021$13,000
-48.0%
1,6140.0%0.00%
Q3 2021$25,000
-30.6%
1,6140.0%0.00%
Q2 2021$36,000
+5.9%
1,614
+44.9%
0.00%
Q1 2021$34,000
+30.8%
1,114
+56.0%
0.00%
Q4 2020$26,000
+420.0%
7140.0%0.00%
Q3 2020$5,000
-16.7%
714
-5.7%
0.00%
Q2 2020$6,000
+100.0%
757
-9.8%
0.00%
Q1 2020$3,0008390.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CANTOR FITZGERALD, L. P. 215,200$4990.01%
Schonfeld Strategic Advisors LLC 142,100$329,6720.00%
TWO SIGMA SECURITIES, LLC 14,877$34,5150.00%
FIFTH THIRD BANCORP 291$6750.00%
FRANKLIN RESOURCES INC 10,997$25,5130.00%
BANK OF AMERICA CORP /DE/ 11$260.00%
PNC FINANCIAL SERVICES GROUP, INC. 142$3290.00%
MONEY CONCEPTS CAPITAL CORP 7$160.00%
WELLS FARGO & COMPANY/MN 1,613$3,7420.00%
NORTHERN TRUST CORP 17,338$40,2240.00%
View complete list of APTEVO THERAPEUTICS INC shareholders